The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
28671460 |
50 |
Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.![EBI](/images/logo_chembl.png) |
Universit£ |
1310118 |
32 |
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding.![EBI](/images/logo_chembl.png) |
Merck Sharp and Dohme Research Laboratories |
28197313 |
17 |
From Dynamic Combinatorial Chemistry to![EBI](/images/logo_chembl.png) |
Universit£ |
27537923 |
31 |
Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.![EBI](/images/logo_chembl.png) |
Universit£ |
26509551 |
31 |
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases.![EBI](/images/logo_chembl.png) |
Pfizer |
25438766 |
38 |
Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.![EBI](/images/logo_chembl.png) |
University of California |
24588269 |
4 |
Biologically active eremophilane-type sesquiterpenes from Camarops sp., an endophytic fungus isolated from Alibertia macrophylla.![EBI](/images/logo_chembl.png) |
Universidade Estadual Paulista |
23581551 |
75 |
Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors.![EBI](/images/logo_chembl.png) |
Universit£ |
22793255 |
16 |
Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.![EBI](/images/logo_chembl.png) |
Universit£ |
18063373 |
11 |
Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.![EBI](/images/logo_chembl.png) |
Universit£ |
21090682 |
48 |
Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.![EBI](/images/logo_chembl.png) |
Universite£? Libre De Bruxelles |
32503688 |
35 |
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).![EBI](/images/logo_chembl.png) |
Novartis Institutes For Biomedical Research |
30613322 |
37 |
Potent Triazolopyridine Myeloperoxidase Inhibitors.![EBI](/images/logo_chembl.png) |
Bristol-Myers Squibb Research and Development |
30466896 |
8 |
The development of myeloperoxidase inhibitors.![EBI](/images/logo_chembl.png) |
University Sarajevo School of Science and Technology |
26487910 |
50 |
Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase.![EBI](/images/logo_chembl.png) |
Emory University |
1732557 |
20 |
Improvements in the minimum binding sequence of C5a: examination of His-67.![EBI](/images/logo_chembl.png) |
Abbott Laboratories |
1372359 |
3 |
Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents.![EBI](/images/logo_chembl.png) |
Warner-Lambert |
20565336 |
24 |
Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.![BDB](/images/logo_bindingdb.png) |
Nanchang University School of Pharmaceutical Science |
19036583 |
18 |
Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement.![BDB](/images/logo_bindingdb.png) |
Merck Research Laboratories |